Back

Myeloperoxidase as a prognostic marker for adverse events in patients with chronic heart failure in 12 month follow-up

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure 1 Biomarkers HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Iulia Rodionova

L.T.Malaya Institute of Therapy, Kharkiv (Ukraine)

4 More presentations in this session

Presentation thumbnail
The MAGGIC score in predicting progression of preclinical heart failure in coronary artery disease
Doctor B. Braganca (Porto, PT)
Abstract Slides
Presentation thumbnail
Usefulness of surprise question to predict short term mortality in advanced heart failure patients
Doctor J. Verdu (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Outcomes among heart failure patients hospitalized for Acute Pulmonary Embolism and Covid-19 infection: Insight from the National Inpatient Sample (NIS)
Doctor B. Casipit (Philadelphia, US)
Abstract Slides
Presentation thumbnail
Prognostic variables of mortality and/or rehospitalization at 30 days in patients with acute heart failure. sub-analysis of the argentine registry of heart failure (argen ic)
Doctor G. Sorasio (Buenos Aires, AR)
Abstract Slides

Access the full session

Session thumbnail
ePosters in chronic heart failure 1

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Presentation
Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation
thumbnail
Congress Presentation
Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources